Compounds for the treatment of metabolic disorders

2008 
The present invention has dual activity as inhibitors of agonists and DPP-IV of GPRl 19, metabolic disorders, related therapeutic compounds such as useful for the treatment of type II diabetes.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []